Articles related to Oncology, Medical

In light of recent disruptions, it’s crucial for healthcare systems to reconsider how consolidation impacts patient care and to explore diverse value-based care models that prioritize patient outcomes.

In a recent phase 3 trial, alectinib has shown a notable improvement in both disease-free and CNS disease-free survival in patients with ALK-positive NSCLC, indicating a robust alternative to platinum-based chemotherapy regimens.

Managing venous thromboembolism effectively demands a nuanced understanding of updated clinical guidelines, which now differentiate treatment protocols based on specific risk assessments and patient comorbidities.

Microscopic colitis, often masked in routine diagnostic evaluations, necessitates a histological approach for accurate diagnosis. The disease’s association with specific medications underscores the need for careful patient medication reviews.

In a recent case, symptomatic joint pain and distinctive physical signs in a patient led to the identification of non-small-cell lung cancer, highlighting the critical role of thorough clinical assessment in revealing potential underlying malignancies.

The recent uncovering of KSHV’s method of commandeering cell metabolism for cancer progression not only highlights a novel therapeutic target but also emphasizes the need for vigilant monitoring in immunocompromised patients, where such viral activations are more likely to precipitate aggressive cancers.